Stay updated on FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial
Sign up to get notified when there's something new on the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page.
Latest updates to the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page
- CheckyesterdayChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with a reference to the Contacts and Locations section.SummaryDifference2%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has added new features while removing extensive options for downloading study data, including various file formats and detailed data fields.SummaryDifference3%
- Check22 days agoChange DetectedSeveral key medical and research resources related to soft tissue sarcoma and treatments like Trabectedin, Ipilimumab, and Nivolumab have been removed from the website.SummaryDifference0.5%
- Check30 days agoChange DetectedThe website has been updated to version 2.12.2, with new resources added including links to MedlinePlus, DailyMed, and PubMed, as well as additional data fields for study information.SummaryDifference4%
- Check37 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check44 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.1%
Stay in the know with updates to FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page.